PROTECT Benefit-Risk

[Drug Safety Research @DSRUDrugSafety]

Our recent systematic #BenefitRisk assessment used the BRAT framework, a 6 step process to support the decision and communication of a benefit-risk assessment, established by @PROTECT_BR https://t.co/AJU83KgMB8 https://t.co/VoFrzUDe2B Paper: https://t.co/k5dbuqNq5W

[PROTECT Benefit-Risk @PROTECT_BR]

https://t.co/41dQKovcEa

[PROTECT Benefit-Risk @PROTECT_BR]

Join us for a dose of benefit-risk assessment! #benefitrisk #rwe #bayesian #jsm2020 https://t.co/s4G4n98J9l

[PROTECT Benefit-Risk @PROTECT_BR]

#benefitrisk https://t.co/OgmMKNGgYZ

[PROTECT Benefit-Risk @PROTECT_BR]

The BRAT framework https://t.co/0BlIlPHDKZ

[PROTECT Benefit-Risk @PROTECT_BR]

#msdemployee https://t.co/LxywRNd6GR

[PROTECT Benefit-Risk @PROTECT_BR]

Awesome milestone. A step closer to better safety. https://t.co/eey3qARFSW

[PROTECT Benefit-Risk @PROTECT_BR]

https://t.co/bUMEVKDo9r

[PROTECT Benefit-Risk @PROTECT_BR]

Postdoc Fellow in Benefit-Risk Assessment. Start ASAP. https://t.co/Wwg9Oayuuy

[PROTECT Benefit-Risk @PROTECT_BR]

Preference elicitation in BR assessment has gained momentum with guidelines being drafted. Do we know how to elicit preferences? A workshop at the PSI conference in London on June 2nd aims to tackle this. For more information and to register please see https://t.co/NQJs8JUTJZ

[PROTECT Benefit-Risk @PROTECT_BR]

NICE provides first scientific advice on patient preference study design https://t.co/pmkRF0tf7b What do you think about it? @PROTECT_BR

[PROTECT Benefit-Risk @PROTECT_BR]

Benefit-Risk Webinar on Patient Preferences (Nov 20th) Open for Registration https://t.co/x9Opo1d5fV via @PROTECT_BR

[PROTECT Benefit-Risk @PROTECT_BR]

Let's learn how to swing in Amsterdam! https://t.co/49WWFYwiI8

[PROTECT Benefit-Risk @PROTECT_BR]

Do all patients have the same benefit-risk balance from the same medicinal product? https://t.co/RXYNQaVMCi

[PROTECT Benefit-Risk @PROTECT_BR]

In the spirit of PROTECT Legacy, #MSD has an opportunity for an exceptional #PostDoc Fellow in #BenefitRisk methodology and machine learning. See more at https://t.co/u10BHHQrWl. @Merck

[PROTECT Benefit-Risk @PROTECT_BR]

28th Nov: Join us in the European Statistical Meeting: Latest Trends in Health Technology Assessments. Register now! https://t.co/LbbmfSn3gs

[PROTECT Benefit-Risk @PROTECT_BR]

4 interesting presentations about benefit-risk from the PAGE conference https://t.co/36PTxO5RMl via @PROTECT_BR

[PROTECT Benefit-Risk @PROTECT_BR]

Public Workshops on Benefit-Risk Considerations https://t.co/TljLu7ESs6

[PROTECT Benefit-Risk @PROTECT_BR]

What is this effects table and why should I create one? https://t.co/hrYp5p6LeT via @PROTECT_BR

[PROTECT Benefit-Risk @PROTECT_BR]

A quick glance on the PrOACT-URL framework https://t.co/Z4tBP7UCdS via https://t.co/pPaxdc8WtT @Eu2P @IMI_JU